Life Sciences: Influenza

Department of Health and Social Care written question – answered on 5th November 2021.

Alert me about debates like this

Photo of Baroness Ritchie of Downpatrick Baroness Ritchie of Downpatrick Non-affiliated

To ask Her Majesty's Government what plans they have to invest in the life sciences sector to support the UK's preparedness against (1) the impacts of season flu, and (2) an influenza pandemic.

Photo of Lord Kamall Lord Kamall The Parliamentary Under-Secretary for Health and Social Care

Given wider preparedness work with the life sciences sector, a specific investment for influenza has not been made. However, Life Sciences Vision, set out the 10 year plan for building on the UK’s life science capabilities with commitments to continue to invest in pandemic preparedness and response, including vaccine development, clinical research infrastructure and National Health Service genomic sequencing capability. This includes a healthcare mission to sustain the United Kingdom’s position in novel vaccine discovery, development, manufacture and use. The report also contains a commitment to build on the UK’s pandemic manufacturing infrastructure, expertise in vaccines and £380 million invested by the Vaccines Taskforce in vaccine manufacturing capacity. A copy of Life Sciences Vision is attached.

The Spending Review also announced a £354 million investment in the life sciences manufacturing sector, including preparing for future pandemics.

Life Science Vision (pdf, 3513.6KB)

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.